Harbin Fuerjia Technology Second Quarter 2024 Earnings: EPS: CN¥0.47 (vs CN¥0.54 in 2Q 2023)

Simply Wall St · 09/01 00:31

Harbin Fuerjia Technology (SZSE:301371) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥530.7m (up 7.1% from 2Q 2023).
  • Net income: CN¥188.7m (down 2.8% from 2Q 2023).
  • Profit margin: 36% (down from 39% in 2Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: CN¥0.47 (down from CN¥0.54 in 2Q 2023).
earnings-and-revenue-growth
SZSE:301371 Earnings and Revenue Growth September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Harbin Fuerjia Technology Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Medical Equipment industry in China.

Performance of the Chinese Medical Equipment industry.

The company's shares are up 8.5% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Harbin Fuerjia Technology, and understanding them should be part of your investment process.